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Abstract
Vaccinations are important factors in the irradication of most communicable diseases.
Tetanus, diphtheria, and pertussis (Tdap) vaccine has been found to decrease the
incidence and further spread of pertussis, and even nullify its existence, yet many
postpartum mothers opt not to receive the vaccination even if eligible to do so. It was
unknown whether clinical nursing staff at the project site had sufficient knowledge about
Tdap vaccine to educate postpartum mothers to accept the vaccine. The practice-focused
question explored whether an educational program and a toolkit implemented for nursing
staff members on the postpartum nursing unit would improve Tdap vaccination rates
among postpartum mothers. The health belief model, theory of planned behavior, and
social learning theory provided a framework for the project. Evidence obtained from the
results of pre- and post-testing of nursing staff on their vaccine-related knowledge and
attitudes showed a statistically significant increase in knowledge (z = -3.366, p = .001).
Descriptive statistics were used to evaluate the change in Tdap refusal after the education.
The use of Tdap vaccine in the postpartum period improved slightly with fewer
postpartum mothers refusing the vaccine in the post-education period. Project findings
showed that providing Tdap vaccine education to clinical nursing staff could prepare
them to teach postpartum mothers about the benefits of Tdap vaccination, which may
improve the percentage of postpartum mothers who will accept the vaccine. Higher
vaccination rates might contribute to positive social change by decreasing pertussis
transmission rates for newborns.
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Section 1: Nature of the Project
Introduction
The Tdap vaccine is commonly used to protect against tetanus, diphtheria, and
pertussis and is routinely given at ages 11-12 as well as a booster every 10 years (Centers
for Disease Control and Prevention [CDC], 2013). In addition to preventing tetanus and
diphtheria, the Tdap vaccine is intended to decrease the incidence of pertussis or
“whooping cough” within the population of newborns through the vaccination of the
mother during the postpartum period (CDC, 2018). A retrospective project during the
years 2010 to 2015 estimated Tdap maternal vaccine administration as being 96.1%
effective keeping a newborn during their first 2 months of life free from contracting
pertussis; and during the first year of life as 69% protected (Baxter, Bartlett, Fireman,
Lewis, & Klein, 2017). A guided educational program and toolkit for the clinical nursing
staff working on the postpartum nursing care unit may be beneficial to assist them in
educating postpartum mothers to make the decision to accept the Tdap vaccination.
Beneficial use of toolkits for knowledge translation among healthcare professionals
allows the nurses to disseminate knowledge; allowing them to inform the mothers about
vaccines, while building their awareness so that a change within their behaviors might
occur (Barac, Stein, Bruce & Barwick, 2014)
Problem Statement
The Tdap vaccine is intended to decrease the incidence of pertussis within the
population of newborns as well as prevent the incidence of tetanus and diphtheria. Three
DtaP (diphtheria, tetanus, acellular pertussis) vaccine doses, which is a lower strength of
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the Tdap and only contains parts of the bacteria (this is what the lower-cased a in
acellular means), is a requirement for infants at 2 to 6 months of age, with boosters given
between the ages of 15-18 months and 6 to 8 years of age (CDC, 2016c). The CDC
advises that everyone acquire a booster every 10 years. However, there are no mandatory
requirements for this booster (CDC, 2015; 2016b). The standard of prenatal care includes
a booster offered between 27- and 36-weeks’ gestation, or in the postpartum period
(CDC, 2016a). However, according to the clinical nursing staff in the project setting,
there are many instances of vaccine refusal. From an internet panel survey of women in
the U.S. in 2015 who did not receive the Tdap vaccine during pregnancy, 43.7% did not
receive the vaccine due to lack of knowledge/awareness; 23.9% due to safety
concerns/risks of side effects; 14.3% stated a lack of concern about pertussis; 11% doctor
recommendation to wait; and 3% stated it was because of a lack of insurance (CDC,
2016a). Postpartum mothers who are not vaccinated with a booster put their newborns at
risk, since research shows that newborns are at a greater risk of contracting pertussis
within their own homes from adults in their immediate environment after leaving the
hospital setting (De Greeff et al., 2010).
The local hospital where the project occurred has its own birthing center which
can care for at least 12 laboring and 14 acute care postpartum mothers. According to my
analysis of the birthing center site, the nursing staff on the postpartum unit consists of
approximately 26 nurses who are in contact with new mothers eligible for the Tdap
vaccine during their 12-hour shifts. All nurses employed at the birthing center are
registered nurses with at least 2 and as many as 30 years’ work experience. The highest
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level of education for nurses who have direct patient contact is a master’s degree. There
are no yearly educational provisions for the nursing staff related to the administration of
the Tdap vaccination provided by the facility beyond the Vaccine Information Sheets
(VIS; CDC, 2015) that the CDC provides on its website as guidelines for vaccine
administration which are available on the unit. When postpartum mothers refuse the Tdap
booster, they may not realize that they are putting their newborns at risk. Nursing staff
members at the project site do not presently teach the mothers the importance of the
vaccination process and simply accept their refusal.
According to the Advisory Committee on Immunization Practices (ACIP; 2013),
studies done on the persistence of antipertussis antibodies in nonpregnant adults have
shown the number of antibodies is higher during the first month after vaccination then
decrease after the first year. Healy, Rench, and Baker (2013) stated that the tested blood
taken after the delivery from the mother and from the infant’s cord blood showed that
antipertussis antibodies from delivery and the cord blood were unlikely going to provide
adequate protection for the infant. They suggested that maternal antibodies waned
quickly if the mothers were administered the Tdap vaccine too far in advance of their
delivery and thus did not provide passive immunity (Healy et al., 2013). The ACIP
(2013) recommends the following:
•

The best time for women to receive the Tdap vaccine is during the third
trimester (30 weeks) to provide the highest level of maternal antibodies.

•

If the last tetanus vaccination administered was more than 10 years ago then a
booster should be given.
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•

Women with unknown or incomplete tetanus should receive three
vaccinations containing tetanus.

Ideally, the first tetanus vaccination should be administered before the woman becomes
pregnant, another at 4 weeks gestation, and the third incorporated as a Tdap vaccination
either in the last trimester or after delivery, during the woman’s postpartum inpatient stay
(ACIP, 2013)
According to the Virginia Department of Health (2018), there were 225 confirmed
cases of pertussis in the state of Virginia in 2016. There was one known case of pertussis
in the city in which the project site was located for a rate of 1 per 100,000 out of a
community population of 96,201 residents. Virginia Department of Health, 2018).
Confirmed pertussis cases in the surrounding communities within the Tidewater Area
consisted of the highest confirmed cases to be from a range of nine to the lowest of zero
confirmations (Virginia Department of Health, 2018). Thus, it is important that guided
nursing education related to the Tdap vaccine be instituted for nursing staff who care for
postpartum mothers at the project site since it is in close proximity to the other
surrounding cities that are having incidences of pertussis.
Purpose
There are multiple reasons why vaccines are not accepted. A person’s religious
beliefs is a commonly expressed reason (CDC, 2018). Another is the unfounded
viewpoint that the vaccines may cause disabilities including mental illnesses and autism
or result in a physical ailment (CDC, 2018). In addition, some mothers verbalize that they
are not sure of what the vaccine is used for or are not familiar with the medication (CDC,
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2018). Increased knowledge in pregnant women during the postpartum period through
educational interventions by health care professionals has a strong impact on their
decision to be vaccinated, researchers have found. This educational process can have a
significant impact on improving vaccination rates, as well as changing attitudes about
vaccination acceptance (Celikel, Ustunsoz, & Guvenc, 2014). The role of the postpartum
nursing staff member in educating new mothers about the Tdap vaccine thus has a direct
impact on whether the Tdap vaccine will be accepted during the postpartum period and
supported the necessity of this project. Therefore, the purpose of this project was to
develop an educational process for the postpartum nursing staff and to provide them with
a toolkit supporting the administration of the Tdap vaccine during the postpartum
inpatient stay for eligible mothers.
At the time that the project was undertaken, there were no tools available to staff
nurses that could potentially be used to facilitate an educational process with patients.
The current process includes the new mother refusing the vaccine and the staff members
simply accepting the refusal while providing minimal literature or professional
knowledge in support of the vaccine. This process represents a significant gap in the
nursing practice at the site. Staff nurses working on the postpartum unit lack resources
that could be used to bring insight to new mothers about the importance of the vaccine.
The prospective of the project leader suggests that nurses fail to comprehend the
immunologic actions of the vaccines and how they are designed to deter the disease
process. Improved familiarity with new developments in immunology through education
can assist nurses to be better equipped in assisting the decision-making processes of
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postpartum mothers (Strohfus et al., 2017). To address the problem of maternal Tdap
vaccination refusal, I sought to answer the following question: Will an educational
program and a toolkit implemented for nursing staff members on the postpartum nursing
unit result in improved Tdap vaccination rates among new postpartum mothers?
Nature of the Doctoral Project
Various quality improvement interventions, committee recommendations, studies,
and surveys support the need for Tdap vaccination interventions and vaccine
administration during the postpartum period (Bernstein, Monty, Yang, & Cohen, 2017;
CDC, 2018). The use of evidenced-based guidelines such as the ones published by the
CDC and the ACIP can assist practices to improve the barriers on the social, economic,
and patient level that impede vaccination acceptance (Gannon, Qaseem, Snooks & Snow,
2012). I used this literature to guide the development of the clinical nurse educational
toolkit that formed the foundation of the training program for the project.
I specifically targeted the education to the clinical nursing staff for the benefit of
the postpartum population. Focused education directed towards the nursing staff
regarding Tdap administration may help to resolve the problem of high vaccine refusal
rates and address the gap in nursing practice by providing informational tools in the form
of pamphlets or handouts to the clinical nursing staff in anticipation of the
counterarguments to refusal. Because there is a lack of vaccine resources available on
Tdap administration for nursing staff to use to convey proper education information to
their mothers during the postpartum period, researchers need to utilize the knowledge
gleaned from existing evidence-based studies in creative ways (Proffeto-McGrath, 2005).

7
The educational program developed for this project was an effort to creatively address the
practice problem.
The approach that was used in this project included the following components: (a)
an educational session for all nursing staff members on the postpartum unit, (b) a pre and
posttest to assess nurses’ knowledge and attitudes towards vaccines that was administered
before and after the education, (c) the development of a toolkit with brochures that were
publicly available to help educate the new mothers on the postpartum unit, and (d)
qualitative debriefing after every educational session to capture staff nurse acceptance or
rejection of the educational program and behavioral intention regarding vaccine
education with new mothers. This project included an educational approach and the
development of materials for staff nurses to use. I did not assess the actual impact on
vaccination as I considered it to be outside of the scope of this DNP project.
Significance
The stakeholder most important to this project was the clinical nursing staff, who
are in a prime position to teach their postpartum mothers about the need for the Tdap
vaccine and to help them to understand the value of protecting their newborn babies from
pertussis. Developing an educational program for the nursing staff members and
providing them with a toolkit will help provide insight into vaccine refusal among the
postpartum population that they serve (Strohfus et al., 2017). When the nursing staff
takes an active role in the education of the mothers, they will be able to turn the vaccine
administration rejections that they encounter into opportunities for positive reinforcement
and adherence to treatment plans (Crawford, Roger, & Candlin, 2018). The clinical
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nursing staff, while using an integrative approach to educate postpartum mothers, could
directly influence them to accept the Tdap vaccine, as well as emphasize healthy
behaviors regarding their infant.
This project may add to the limited knowledge that the participating clinical
nursing staff members have concerning the Tdap vaccine. Any increase in knowledge
that the clinical staff obtains from utilizing the toolkit daily in practice and from the
educational presentation implicit in the project could potentially result in the positive
outcome of postpartum mothers being able to make an educated decision on whether to
become vaccinated with the Tdap vaccine. This project is transferable to any healthcare
setting where nurses are giving vaccinations to clients. Nurses working in the outpatient
antenatal clinic might also benefit from this educational program and toolkit. In designing
the project, I anticipated that the information provided in it would give the participating
nursing staff valuable insight and tools to use in convincing and persuading new mothers
that the vaccination is more beneficial than dangerous (Song, 2014).
An implication for positive social change is that the provision of focused nursing
education through this project may positively contribute to infant health. As more
mothers gain access to the Tdap vaccine, the higher the immunization rates reducing the
incidence of pertussis and the potential for an outbreak of the disease (Bernstein, Monty,
Yang & Cohen, 2017). The education that the nursing staff received during this project
was specifically targeted to the population of postpartum mothers of newborns since prior
research suggests that newborns are at a greater risk of contracting pertussis within their
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own homes from adults in their immediate environment after leaving the hospital setting
(De Greeff et al., 2010).
Summary
In reviewing the literature, I found no evidence showing that postpartum mothers
do not want to keep their infants safe from pertussis. The Tdap vaccination is one way in
which these mothers can do so even before the birth of their newborns. However, without
the proper education from nursing staff, many will choose to refuse the vaccine putting
their newborn at risk. The project emerged from the lack of information available to
postpartum nursing staff at the project site and their inability to proficiently teach
postpartum mothers so that they could make an educated decision about the Tdap
vaccine. This project has the potential to change how nursing staff members engage with
new mothers around this important issue, which may result in improved Tdap vaccination
rates among new mothers.
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Section 2: Background and Context
Introduction
The Tdap vaccination decreases the incidence of pertussis within the newborn
population, especially when the vaccine is administered to mothers during the postpartum
period. Receiving the vaccination during this time frame is pivotal since mothers who
refuse the vaccination place their newborns at an immunological disadvantage and at a
greater risk to contract pertussis post hospital discharge (De Greeff et al., 2010). This risk
can be greatly minimized if postpartum mothers realize the benefits of having the Tdap
vaccine administered after giving birth (Dempsey et al., 2016). The focus of this project
was on decreasing Tdap administration refusal during the postpartum period through the
provision of targeted vaccine education for the clinical nursing staff. To address the
problem of maternal Tdap vaccination refusal, I posed the following question: Will an
educational program and a toolkit implemented for nursing staff members on the
postpartum nursing unit ultimately result in improved Tdap vaccination rates among new
postpartum mothers?
The purpose of the project was to examine how the use of specific education for
the clinical nursing staff could positively influence postpartum mothers and their decision
to accept vaccines. General literature is widely available that correlates education with
health broadly (Eide & Showalter, 2011). Cook (2015) asserted that lack of knowledge
limited a person’s choices, potentially leading to poor choices in health care. Included in
this section are an overview of the concepts, models, and theories used in the project; a
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consideration of the relevance of the problem to nursing practice; local background and
context; and discussion of the role of the DNP student.
Concepts, Models, and Theories
I used three learning models for the project. The first was the social learning
theory of Bandura (1988) which postulates that the clients’ behavior will change based on
their expectations and incentives. The second was the theory of planned behavior of
Fishbein and Ajzen (1980), which suggests that people already have preconceived
behavioral intentions that will lead to predictable outcomes regardless of what knowledge
that they are exposed to (see, also, Madden, Ellen, & Ajzen, 1992). Last, I used the health
belief model, which focuses on attitudes and beliefs about the behavior, perceived
benefits, perceived barriers, perceived susceptibility, perceived severity, self-efficacy,
and cues to action (Myers, 2016).
Social Learning Theory
The determination of incentives forms the basis of social learning theory.
Incentives within social learning theory consist of how much the postpartum mother
values the outcome and whether the outcome is the positive approval of others, increased
health, or positive/negative consequences (Rosenstock, Stretcher, & Becker, 1988). The
client’s behavior is determined by the interpretation of consequences by the postpartum
client (Rosenstock et al., 1988). Within this theory, the postpartum mother will only
accept the vaccine if she believes that her lifestyle is threatening an outcome that is
considered valuable, if behavioral changes reduce threats to the outcome, and if she
believes that she can maintain or adapt to the change (Rosenstock et al., 1988).
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Theory of Planned Behavior
Many pregnant women receive extensive information from magazines, social
media, and their healthcare providers about vaccines (Ellingson & Chamberlain, 2018).
Prior knowledge of vaccinations can become a hindrance to a client, just the same as not
having prior knowledge (Myers, 2016). The application of the theory of planned behavior
within this project is to assist the pregnant or postpartum women in understanding the
relationship between their beliefs and their behaviors so that they will be able to deduce
information that will assist them in the decision of accepting or declining the Tdap
vaccination (Jalal-Eddeen & Abdelrahim, 2015). The new mother’s beliefs in this model
are an influence on whether she accepts the vaccine.
Health Belief Model
Within the health belief model, the patients work within the constructs of their
perceived seriousness of the need for the Tdap vaccine and their perceived risk or
susceptibility of getting the disease which would make them exhibit behaviors to either
do something to prevent getting the disease or to do the opposite. However, if the patients
perceive that there are benefits to taking the vaccine, then they will adopt healthier
behaviors. The individual may perceive barriers as the obstacles in the way of them
adopting the new behavior. The new behavior can be modified by other variables such as
culture, education level, skills, past experiences and motivation (Jones & Bartlett, N.D.).
These cues to action are what moves the patients to change their behavior. Self-efficacy
is evident only if patients perceives that they can do the tasks.
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Tdap Vaccinations in Pregnancy
Receiving the Tdap vaccination during pregnancy is a benefit for the mother as
well as the unborn fetus in that the mother is prevented from contracting maternal
illnesses and can positively respond to active immunizations. The benefit for the fetus is
due to the transplacental transfer of maternal antibodies past the third trimester
decreasing the risk of adverse fetal development (Munoz, 2007). However, in women
who have not had advice on this topic prior to delivery, discharging the mother to home
without the vaccine puts the infant at risk. Because the Tdap vaccination for infants less
than two months old is not an option, clinical nursing staff must inform and educate
postpartum mothers that receiving the Tdap vaccination can prevent catastrophic illness
and disease (Silverman, 2014).
According to the CDC (2018), in 2016 there were 17,972 reported cases of
pertussis with six reported deaths of children under the age of one year. This is a decrease
from the 20,762 reported cases in 2015. The incidence of pertussis is the primary reason
why maternal vaccination is so important. Healy, Ng, Taylor, Rench, and Swaim, (2015)
conducted a project that provided the details of the Tdap uptake in pregnant women
receiving prenatal care in a tertiary referral hospital in Houston, Texas. Tdap acceptance
was increased after educational interventions and improved provider education resources
were made available. During this study, 3,678 women (55.9%) were vaccinated with the
Tdap vaccine, 100 (1.5%) women were vaccinated antenatally, 249 (3.8%) were
vaccinated postpartum increasing those women who were vaccinated to a total rate of
61% from April 2013 to November 2013. The study suggests that by increasing the
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provider’s awareness of the new immunization recommendations, and improving the
provider’s education would be the prerequisites needed for increasing the hospital’s Tdap
immunization rates. However, education initiatives will still need to be maintained
regularly to continue to increase the vaccine uptake among pregnant women which
suggests that they are not reluctant to be immunized (Healy, et al., 2015).
Barriers to Tdap Booster Use
According to Munoz (2007), barriers exist whether perceived or actual resulting
in the lack of the acceptance of the Tdap vaccine postpartum. These include but are not
limited to: (a) the lack of scientific controlled studies supplying data supporting the use of
the Tdap vaccine during and after pregnancy, (b) lack of training for nurses about
immunology, (c) the amount of clinician time needed to educate and consent mothers,
and (d) the lack of confidence in vaccine safety.
In a study conducted by Cheng et al. (2010), the researchers used surveys to
ascertain the reasons why postpartum women would either decline or accept the Tdap
vaccine for pertussis postpartum. This study took place in the Taiwan 3,000 bed teaching
hospital which delivers 5,000 babies annually. This study included participants who
accepted or declined the Tdap vaccine between May 2009 and October 2009. In April
2009, the healthcare providers which included physicians, labor and delivery and
postpartum nurses, nursing administrators, and pharmacists all received educational
training consisting of obstetrical grand rounds, workshops, and case discussions. The
mothers who participated were given educational packets with the VIS information
leaflet, “What you should know about infant pertussis”, and a video that had data on the
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efficacy and safety of the Tdap vaccine. Lastly, during prenatal visits the mothers were
educated by a trained nurse who briefed them on the vaccine. After the mothers
delivered, they were given a letter of intent to vaccinate form for a response of either “yes
or no” while nursing staff were available to answer any questions. Women who
consented to the vaccine had it administered before discharge from the hospital. All
participants were given a three-page 25 question multiple choice survey to complete that
discussed their concern for vaccine safety, demographic information, their access to
information, how credible the information was, and factors of influence on their decision.
Chi square analysis and generalized estimation equations approach to logistic regression
were used to associate between the primary outcome variable and survey responses. Four
variables explained the factors influencing mothers’ decision to decline the vaccine in the
postpartum phase: (a) low perception of maternal risk of exposure to pertussis in the
postpartum period, (b) low perception of risk for infants 0 to 6 months old to contract
pertussis, (c) lack of trust about information presented, and (d) a high level of concern
regarding the safety of the vaccine. Contrariwise, there were six demographic
characteristics that contributed to vaccine decline, significant (p<.01). Women who were
aboriginal, with low education levels, lower family income, with fewer prenatal visits,
who bottle-fed their babies were also more likely to decline the vaccine (p<.01). Those
women who declined the vaccine reported not receiving enough information and did not
trust the information that was received about the vaccine. The study results suggested that
the mothers would more than likely accept the Tdap vaccine if their clinicians discussed
the postpartum vaccination program with them. Lastly, results showed that before the
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women were discharged from the hospital, many different forms of educational material
in every language and for all educational levels should have been presented at multiple
times in order to capture the majority of mothers who would accept the Tdap vaccine
(Cheng et al., 2010). Although this study presents information from a culturally different
perspective as compared to this DNP study setting, the implications regarding the need
for education in the postpartum period and the barriers that health professionals face are
still relevant.
In another study, an education barrier related to the acceptance of the Tdap
vaccine during mother’s postpartum period was researched in Houston at the Ben Taub
General Hospital (BTGH), which delivers 5,000 babies annually to the underserved
population of mostly Hispanic and African American mothers. The study was conducted
between January 7 and April 30, 2008 (Healy, Rench, Castagnini, & Baker, 2009).
During this study, focused education was given to physicians, nursing staff,
administrators, and interpreters via educational in-services, and obstetrical grand rounds.
The VIS and bilingual leaflets were given to the mothers, and vaccination posters were
visible; while nursing staff and physicians were available to answer the questions of the
postpartum mothers. The Tdap vaccine was offered to 1129 of 1570 postpartum mothers;
72% (n=1129) of those mothers accepted the Tdap vaccination which resulted in a 92%
vaccine uptake; 396 were excluded due to receiving tetanus toxoid, no order, or
medication contraindications, and 441 women were not immunized. (Healy et al., 2009).
The contributing factor of why so many postpartum mothers accepted the vaccination
was because of the focused, intensive education that the nursing and physician staff
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received, and how well they responded to the lecture style education. The nursing staff
became powerful vaccine advocates, who incorporated the education they received into
routine postpartum information making the education they received the best strategy for
maternal Tdap acceptance (Healy et al., 2009). The study also further suggested, that
even though there were decreased Tdap refusals through the provision of the formal
education by the nursing staff, African American mothers were still distrusting of Tdap
vaccine acceptance over other ethnicities. The researchers of this study at its completion
revealed two poignant findings. Healy et al. (2009), suggests that increased immunization
rates would have occurred if the type of education strategy used would have been started
earlier during participants pregnancy to sustain the education use longer over time, and
that the education should have been given to them by nurses or healthcare professionals
who they considered a trusted source of information (Healy et al., 2009).
Kriss et al. (2017) conducted a randomized controlled trial to pilot two
educational interventions provided by medical staff: an iBook and a messaging video,
which would be used for recruited African American pregnant women based on the
Elaboration Likelihood Model (ELM) framework to improve the uptake of health
maintenance interventions during the perinatal period to improve maternal vaccine
receipt. To utilize this framework the description of how information is received and
processed is noted by the healthcare professional. There are two ways this can be done;
through central processing, and through peripheral processing. Central processing means
that the person is motivated to analyze information that is personally relevant and
information based. Contrariwise, peripheral processing uses simple messages and
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information to create less enduring behavior changes (Kriss et al., 2017). This study took
place in Atlanta, Georgia’s metropolitan area, and included women ages 18–50 years
with an expected delivery date of January 30-June 30, 2013. Participants received
monetary gifts of a gift card of $50 if they completed the trial. Women who already had
received the Tdap vaccine were excluded. Each woman was assigned to either the control
group or to one of the vaccination education interventions (a) the messaging video
“Pregnant Pause” or (b) a messaging iBook “Vaccines for a Healthy Pregnancy.” Both
only took 20 minutes to view. The video had very detailed Tdap vaccine information
from a physician discussing the severity of pertussis, how vaccines protect the mother
and infant, and current ACIP recommendation. The iBook had Tdap information in the
form of a tutorial that excluded parental testimonials of when their infant contracted
pertussis. Information was given in question and answer format on the safety of the
vaccine, and current ACIP recommendations. The control group only received the VIS
paper that did not have any interactive formatting nor any information for pregnant
women were included. They also did not receive a post intervention questionnaire as the
women did who used one of the other two interventions. Sample size was determined to
reduce the chance of a type 2 error, with an apriori power analysis of 80% and a
minimum sample was set at 162 women (54 women in each intervention). There were
741 women who were approached to participate, 224 (30%) declined, 392 (53%) were
ineligible, 125 women were eligible but only agreed to participate (85%). After the study,
95 women completed follow up after delivery (34 in the control group, 31 in the video
group, and 30 in the iBook group) resulting in a sample somewhat smaller than originally
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planned. Chi square and t-tests showed no significant differences between the groups on
demographic characteristics, assuring that true randomization occurred. For this study
they wanted an 80% power to detect a 20% increase in vaccine coverage. The needed
participation needed to include 162 women with the expectation of 52 women in each
control group, but the target sample was not reached by the recruitment period having
limited power to detect effects. The study resulted in 18% of women in the control group
who were vaccinated with the Tdap (6% while pregnant and 12% postpartum), in the
iBook group 50% of the women received the Tdap in the perinatal period (7% during
pregnancy, and 43% postpartum), and in the video group 29% received the Tdap (6%
during pregnancy and 23% postpartum). In conclusion, it was found that the women who
were in the video group were more engaged than the iBook group and could relate to and
understand the educational information more; feeling that there was evidence to support
it. The participants who did not receive the Tdap vaccine reasons were that they did not
receive a physician recommendation, did not know about the vaccine, did not feel that
they were at risk, did not know what it was for, and lastly that they just do not use
vaccinations. This study concludes, that a more interactive form of education provided by
clinical nursing staff would be beneficial in providing targeted education for the
promotion of Tdap uptake and behavioral changes during the postpartum period to
promote Tdap uptake.
Definitions of Terms
For this project, the following words that are in no specific order in italics have
been defined.
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Tetanus Diphtheria and Pertussis Vaccine (Tdap)- Vaccine used for protection
against the diseases of tetanus (lockjaw), diphtheria (thick coating on back of throat) and
pertussis (whooping cough) which are contagious and can be spread through coughing
and sneezing, scratches, cuts, or wounds. (Center for Disease Control and Prevention,
2015).
Antenatal- The care and treatment of pregnant women and their unborn child.
(Merriam-Webster Dictionary, accessed November 15, 2015 at http://www.merriamwebster.com/dictionary/antenatal)
Postpartum- Relating to or happening in the period following the birth of a child.
(Merriam-Webster Dictionary, accessed November 15, 2015 at http://www.merriamwebster.com/dictionary/postpartum)
Maternal- Relating to a mother or a woman having a baby. (Merriam-Webster
Dictionary, accessed November 15, 2015 at http://www.merriamwebster.com/dictionary/maternal)
Clinician- a person qualified in the clinical practice of medicine, psychiatry, or
psychology as distinguished from one specializing in laboratory or research techniques or
in theory (Merriam-Webster Dictionary, accessed November 15, 2015 at
http://www.merriam-webster.com/dictionary/clinician).
Relevance to Nursing Practice
The medical profession, which consists of nurses, midwives, and obstetricians, are
major contributors of current and available information that is available to provide
needed education regarding Tdap to mothers after having their babies on the postpartum
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unit. Variables related to this somewhat controversial subject include whether the vaccine
is safe to be administered to pregnant women, legal and economic issues, ethical
concerns, emotional overlays, and the role of the media. Much of the evidence for the
benefits of pertussis vaccination arises from epidemiologic studies regarding the
incidence of the disease and the effectiveness of the vaccine in preventing it. The very
nature of epidemiologic data has contributed to the controversy, since there is virtually no
epidemiologic study with incontrovertible results that allows only one interpretation
(Hinman, 1984). Smith et al. (2011) suggests the key rationales listed within Public
Health Report literature as far back as 1969, states that parental decisions related to the
administration of vaccines are psychosocial in nature; and manifested by the seriousness
of health concerns and risks involved, the assessment of whether the disease would be
transmitted, outside influences as to whether it was feasible to have vaccinations
administered.
For this project, the question of whether knowledge deficits and insufficient
education of clinical nursing staff affects vaccine acceptance among postpartum mothers
is raised. Strohfus et al. (2017) conducted a project implementing the Immunization
Education Program to meet four objectives: (a) develop education and training, (b)
assess knowledge levels in the subject of immunizations, (c) increase immunization rates,
and (d) identify challenges that may affect immunization practice knowledge and
decrease immunization rates (Strohfus et al., 2017). The study took place in Health
District 4 which offer services in community and reproductive health, communicable
diseases, WIC, and immunizations. There were 50 medical offices out of 98 asked to
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participate in the study. Total staff participants included 179, of whom 113 finished the
pre-test, education/training, and 12-month post-test. The test used for the study was the
Immunization Knowledge Assessment Tool (IKAT-G) which was slightly modified
adding in six extra questions including demographics. Medical staff who participated in
the study included registered nurses, licensed practical nurses, doctors, medical assistants,
and nurse practitioners. Participants received four peer to peer one-hour immunization
education training sessions over four weeks that included topics covering evidence-based
immunization strategies, protocols, vaccine schedules, injection techniques, and
documentation in the form of lectures, simulations/demonstrations, handouts, and small
group discussions (Strohfus et al., 2017). After the participants were educated, they were
given follow-up training after six months which included immunization data rates,
practice challenges, documentation in the Immunization Information System, and in
storage/handling. The results of the study consisted of pre-post differences in means and
the 12-month post-education test mean using the chi-square test where the p value of <
0.05 is considered statistically significant (Strohfus et al., 2017). Each score for every job
title was then compared to the pre-post testing to find that the participants mean
knowledge level had increased overall 7.8% which was 2.0% less than their set goal for
this particular area of improvement. (Strohfus et al., 2017). The pre-test resulted with a p
value of <0.01 and a post-test p value of 0.97. So, in conclusion, when education and
training was given over a shorter period, increased competency was noted, and when
education was given over a longer time frame it was harder to maintain competency and
education needed to be given continuously (Strohfus et al., 2017).
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The intention of this study was to fill the gap in practice and advance the practice
of the current nursing staff members on the postpartum unit. As mentioned previously,
nurses did not have the tools necessary to increase their knowledge related to vaccines
and their use. The provision of education via a toolkit including information about the
Tdap vaccine would assist in increasing nurse competency and current administration
practices, thereby giving them the proper leverage needed to provide education to the
postpartum population.
Local Background and Context
The purpose of the proposed project is to begin the process of educating the
postpartum mother as soon as possible post delivery about the pertussis vaccine. All
postpartum mothers who have not already received the Tdap vaccination between 27-36
weeks of pregnancy are eligible to receive the vaccine. Within the last six months, an
estimated 60 eligible postpartum mothers did not receive the Tdap vaccination. The
foundation of education about the vaccination sets the tone and pace for the project by
purposefully supplying written literature and verbal education during the mother’s
postpartum period before discharge from the hospital. By educating the nursing staff on
the postpartum unit, the nursery staff, as well as the labor and delivery staff, the DNP
project provides the groundwork to formally educate the mother as early as possible after
she has labored and after delivery. The intention is that the mother is therefore well
informed about the pertussis vaccination in the likelihood that the vaccination is viewed
as a positive choice and is consented by the mother to be administered by the clinical
nursing staff during the postpartum period before her discharge from the hospital. The
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education provided to the nursing staff members will help them to examine their own
perceptions about the Tdap vaccine, and vaccines in general. By doing so, these nurses
will be in a better position to refute and debunk any myths or misconceptions that new
mothers raise when confronted with the decision to vaccinate or not (Unisa, 2017).
Education will be provided to the 29 registered nurses who staff the birthing
center to include all labor and delivery, nursery, and postpartum nurses since they all
come in contact with the mothers and have the opportunity to provide Tdap vaccination
education post-delivery. These nurses will receive education within one session during
their scheduled monthly staff meeting, with a follow-up session to take place a few weeks
later.
It is essential that the nursing staff is cognizant of the concise definitions of
locally used terms since they are responsible for educating postpartum mothers.
Knowledge of locally used vaccine terminology is important since most of the acronyms
related to the pertussis vaccine are similar and can cause confusion for the postpartum
mother. Other definitions of local terms related to the pertussis vaccine that is relevant to
understanding this doctoral project, and assists to further differentiate the types of
pertussis vaccines and who can use them are:
Acellular pertussis vaccine- A vaccine composed of only those fragments of
bacterial cells that are best suited to stimulate a strong immune response (American
Heritage Medical Dictionary, 2007).
Whole cell pertussis vaccine- A vaccine prepared from suspensions of the inactive
bacterium that cause the pertussis disease (Riley & Eckert, 2015).
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DTap- A preparation of diphtheria and tetanus toxoids and acellular pertussis
proteins used to immunize children against all three infections or adults at high risk of
complications of infection with pertussis (Medical Dictionary, 2009).
DPT- An active immunizing agent for the routine immunization of children less
than six years of age against diphtheria, tetanus and pertussis (Mosby’s Medical
Dictionary, 2009).
This project will initially begin with the investigation of the Tdap vaccine for
postpartum women legally under the provisions set by the state of Virginia. Legal
requirements would have to be verified before the proposed project can be used related to
public health laws, state statutes and regulations which requires the facility to assess the
client’s vaccination status, the ability to offer the vaccination to the client, and
administrative requirements for ensuring that the client has been given the vaccine unless
they have refused them (CDC, 2017).
Role of the DNP Student
Motivation for this project was the realization that while becoming more involved
in the facility’s obstetrical population, there was a visible trend of postpartum clients who
were, for different reasons, declining the administration of the Tdap vaccination. What
was noticeable within this population of clients was the observation that they had not
received much, if any, education regarding Tdap vaccine use. The implementation of this
proposed project may support the suggested theory that intentional focused education
during the postpartum period of pregnancy will greatly influence; if not change the
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perception of the mothers about the Tdap vaccine, which would lead to more postpartum
mothers consenting to its administration.
The DNP student’s role will consist of the creation of a toolkit. This toolkit will
include the educational material that the clinical nursing staff will need to increase their
knowledge base to support them when they eventually provide Tdap vaccination
education to their postpartum mothers. While being able to provide persuasive strategies
that the nursing staff can use to refute vaccine refusal from the mothers, the DNP student
will also provide them with resources available in an attempt to eliminate any barriers
within the staff’s mind to debunk vaccination myths and misconceptions. Biases may be
related to the awareness that most of the clinical nursing staff at the birthing center
already have prior knowledge of the project’s topic, which may lead to the participants
having enough time to form their own personal opinions on the subject.
There is presently a standing order for the administration of the Tdap vaccine in
the postpartum period. However, there has been no staff education on the topic, and
patient education materials associated with the vaccine are not used by staff nurses very
often. Designing and implementing both an education program and a toolkit for staff
members to use when teaching new mothers about the importance of the Tdap vaccine in
the postpartum period. The purpose of the DNP project is to develop and implement an
educational program for staff nurses working on the postpartum unit at the project site
and a toolkit for the nurses to use in teaching new mothers about the importance of the
Tdap vaccine. Ultimately, it is the intention of this project to positively influence vaccine
uptake rates, however, this is out of scope of the DNP project.
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Summary
In summary, of all outcome measures available, knowledge is used the most to
gather new information and assist with decision-making (Smith, et al. 2012). Clinical
nursing educational strategies for instructional information for postpartum mothers
relating to the Tdap vaccine and its acceptance is needed. However, not only are
educational strategies needed for clinical staff and postpartum mothers; the advancement
of nursing practice can be synonymous with guided studies focusing on the value of
nursing education and vaccine uptake. The advancement of nursing practice includes
nursing and client reactions to certain contexts of health care, while being able to focus
on the specific healthcare needs that require nursing solutions that can be used to guide
nursing practice (Swartz, 2014).
This project proposal fills the gap in nursing practice concerning the lack of
current research and knowledge that is available on how vital current educational
resources are for the postpartum population who must make decisions on the adherence
of the Tdap vaccine according to the current CDC guidelines. Postpartum mothers who
are exposed to educational interventions by healthcare professionals are impacted
strongly by changing their attitudes on Tdap vaccination acceptance, and by increasing
vaccination rates (Celikel et al., 2014).
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of this project was to provide education to the postpartum nursing
staff about the importance of Tdap vaccine education at the participating DNP project
site. The education received by the nursing staff and materials provided in the toolkit
were relayed to mothers during their postpartum period encouraging them to accept the
Tdap vaccine before discharge from the hospital. In this section, I will discuss procedures
for collecting and evaluating evidence as well as the tools and techniques used during the
project.
Practice-Focused Question
As the challenges concerning the administration of the Tdap vaccination for
postpartum mothers increase, so do the chances that infants will contract pertussis during
the 2-month neonatal period and before they are vaccinated themselves (American
College of Obstetricians and Gynecologists, [ACOG] 2017). For this reason, I relied on
current research sponsored by governmental agencies such as the CDC and adopted by
nurses who provide daily care. Celikel et al. (2014, p. 2148) explained that health
professionals play a pivotal role by helping pregnant women sort through various
information sources. By providing formal education during the postpartum period nurse
educators can guide nursing practice to prevent the disease of pertussis in infants which
could be perpetuated by the refusal of the Tdap vaccine.
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Providing focused education to nurses regarding the Tdap vaccination for
postpartum women has resulted in a positive increase in vaccination rates, as well as
introduce new educational practices (Healy et al., 2009). In one project, the creation and
repeated delivery of new educational interventions ensured that the Tdap vaccine was
delivered to the greatest number of maternal women before discharge from the hospital
(Kao et al., 2012).
Throughout the scope of this DNP project, the organization evaluated the effect of
the toolkit and the focused education provided for the nursing staff on the postpartum
mothers’ decision to either accept or to decline Tdap administration within the allotted
time frame before discharge. According to Polit and Beck (2010), causality within
evidence-based practice searches for answers to questions about causes and effects.
Furthermore, it suggests that since most causes may not be deterministic (e.g., the
receiving of education), the probability that an effect will occur (e.g., the mother will
accept the vaccine since she is now more knowledgeable of what it is and how it can
affect her baby positively) may be increased (Polit & Beck, 2010, p. 224). Thus, the
practice-focused question for this project was: Will an educational program and a toolkit
implemented for nursing staff members on the postpartum nursing unit result in improved
Tdap vaccination rates among new postpartum mothers?
Sources of Evidence
Sources of evidence included findings from pre- and post-education Tdap test
results and overall Tdap administration statistics before and after the nursing staff
received Tdap education. Other evidence included participants’ responses to the

30
knowledge and attitude scales. Nurses at birthing centers are one of the most important
providers of care and influential sources of education for their mothers (Paterson et al.,
2016; Dube et al., 2013). Implementation of the education from the toolkit enhanced the
knowledge that postpartum mothers already had about the vaccine, it effectively informed
those mothers who were lacking information about the vaccine, or the toolkit fostered at
best a different way of thinking about the Tdap vaccine that was more positive than the
previously negative feelings encountered by the nursing staff. I expected that the
transferred new vaccine knowledge from nursing staff would prompt the mothers to
consent to the administration of the vaccine before discharge from the birthing center.
Statistical data showed that after the clinical staff received the Tdap education and
subsequently educated the postpartum mothers, the birthing center observed a slight
increased overall uptake of the vaccine. The Tdap vaccine education and vaccine uptake
promoted procedural changes within the birthing center. The evidence obtained from the
data showed the relationship that Tdap education had on the nursing staff and their
overall ability to transfer their learned knowledge about the vaccine to their postpartum
mothers.
Published Outcomes and Research
I searched the literature using Sage Full-Text Collection, Ovid, CINAHL
Complete, PubMed, EBSCOhost, ERIC, Wiley Online Library, Cochrane Database of
Systematic Reviews, ProQuest, Medline, and Google Scholar databases. Search terms
used included pertussis pertussis and parental education, pertussis education, nursing
and pertussis, vaccinations and pertussis, knowledge and pertussis, postpartum and
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pertussis vaccine, antepartum and pertussis vaccine, vaccination education, nurses and
vaccine education, maternal vaccination, vaccine uptake, predictors, barriers, and theory
of planned behavior.
Evidence Generated for the Doctoral Project
Participants. At the time of the project, there were 26 nurses who worked at the
birthing center on two shifts. These nurses were the target of this DNP project and all
attended mandatory educational program about the importance of the Tdap vaccine, an
examination of their own attitudes towards vaccinations, a review of the standing order,
and the patient education materials that were included in the toolkit used in the
educational program. The project participants were recruited from the birthing center
located within a local hospital in Virginia. The project design included all 26 clinical
nursing staff members with varied years of experience. Education was provided as a
mandatory in-service and self-paced training packet.
Procedures. Before the initiation of the project, an expert panel that included the
director of the birthing center, members of the hospital’s education department, and the
clinical care leaders of the birthing center observed a presentation of the education that
was provided electronically to the clinical nursing staff. I included this step so that key
stakeholders could evaluate the educational content before it was presented to the staff.
This presentation lasted for 30 minutes and included the teaching packet for review that
was to be included in the clinical nursing staff education session.
Members of the expert panel received a copy of the American College of
Obstetricians and Gynecologists (ACOG) committee opinion statement, copy of the pre-
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test and post-test that was used to assess nursing knowledge (see Appendix A), the
attitude survey (see Appendix B), Tdap Toolkit (see Appendix C), a Tip Sheet (see
Appendix D), and the educational program curriculum (see Appendix E). After the expert
panel approved the educational packet, I then presented the education in an in-service
type setting for the clinical nursing staff to review the educational self-paced package
within a certain period of time.
The expert panel reviewed the pre- and posttests, which are described in
Appendix A, for face and content validity. Face validity measured that the desired
concept of interest was within the test through subjective judgement (Drost, n.d.).
Content validity measured whether the scope of the concept was clear and were
represented within the test (Drost, n.d.). There were 10 questions on the test, each worth
10 points, resulting in a score between 0 and 100. In addition, there were also a five-point
10 question Likert scale, which also resulted in a score that ranged between a low of 1
point for negative responses and 5 points for positive responses. Likert scale options
included responses from strongly disagree to strongly agree. Both the knowledge test, and
the attitude tests were measured at the interval level. The tools have not been used in the
past and were tested in the DNP project for internal consistency reliability.
Before the staff reviewed the educational material, a 10-question pre-test to assess
prior knowledge were given to all staff nurses to establish a baseline. This was
administered during a staff meeting to include as many birthing center staff as possible.
The 10-question post-test to potentially show the improvement of the staff nurses’
knowledge base related to the importance of Tdap vaccines, and a secondary evaluation
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of their attitudes related to the vaccine was conducted a month later at another staff
meeting. After at least 90% compliance were achieved with the self-paced informational
sessions, tests for internal consistency reliability were conducted.
Protections. For the proposed project to be successful, relationships between the
project leader, participants, and the institutional stakeholders were vital. These
relationships previous to the beginning of the project, as well as after its conclusion
showed that by emphasizing the integration of new knowledge within the clinical care
setting prior to practice engagement within the project; and the obtainment of mutual
trust, ensured that the findings were relevant to the community they served (Spears, et al.
2014). The current clinical nursing staff were utilized within the project to make the
results relevant, sustainable, and potentially, permanent (Spears, et al., 2014). Ensuring
that the nursing staff were knowledgeable, while maintaining a relationship with
stakeholders who were aware of the project and were supportive was beneficial since
project related issues may have arose. Positive outcomes related to stakeholder
relationships created future opportunities for research studies.
The protection of the participants of this project were important in that all
information obtained was kept in the strictest of confidence. All data collected from staff
members, i.e. the pre and post test results were submitted with a code number so that
anonymity was evident. The proposed project was guided by the Walden Institutional
Review Board (IRB) whose purpose was to ensure that all proposed projects and research
studies were following federal guidelines, as well as the university’s ethical standards
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(Walden University, 2017). The approval number from the Walden IRB for this DNP
project is 09-07-18-0478414.
Analysis and Synthesis
To maintain evidence integrity and consistency, subject codes and identification
numbers were applied to all instruments utilized throughout the project. Computers were
used for data storage and data collection immediately after retrieval from nursing staff
and backed up to ensure not being misplaced. Data analysis was completed using the
software Statistical Package for the Social Sciences version 25 (SPSS). For this project,
data analysis consisted of three types including: a) internal consistency reliability for the
knowledge questions and attitude questions, b) Wilcoxon Signed Rank test on knowledge
test questions, and c) a Wilcoxon Signed Rank test on the results of the attitude survey.
The created pre- and post-test to assess the clinical nursing staff’s knowledge of
the Tdap vaccine consisted of 10 multiple choice questions with which the nursing staff
were scored from 0-100. This test was verified for content and face validity using a panel
of five experts from the clinical agency’s education department to correlate items within
the test. The expert panel ensured that all included items on the pre-test measured the
concepts related to the Tdap vaccine (Groves, Burns, & Gray, 2013, p. 391). The positive
outcome of the educational process allowed the staff to enhance their clinical judgment
and promoted the provision of quality care (Craig & Smyth, 2012; Eizenberg, 2010;
Groves, Burns & Gray, 2013, p.12). To minimize the possibility of extreme outlier
results, all data was scrutinized for errors during recording and the uploading of data.
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Missing data elements from the knowledge and attitude survey results were not included
in the final analyses.
In addition to expert panel review for validity, the knowledge and attitude survey
scales were also measured for internal consistency reliability. The 10-question knowledge
survey scored .629 using split half reliability for internal consistency. The attitude survey
(also 10 questions using a semantic differential type response format) scored Cronbach’s
Alpha of .70.
Summary
In summary, the collection of data for this project focused on the question of
whether Tdap vaccine education provided to the nursing staff would affect a positive
change in the uptake of Tdap administration among postpartum mothers. The foundation
for data to support this project came from searching various resources to project multiple
viewpoints. Statistical data had to be carefully gathered from the project participants to be
organized, coded, and stored properly to minimize the potential for loss or errors. This
data gathered from the knowledge based pre- and post-test, scales and other instruments
were uploaded in the SPSS system immediately after being obtained while being
scrutinize for outliers and missing information in preparation to explain the findings and
implications.
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Section 4: Findings and Recommendations
Introduction
The Tdap vaccination is used to vaccinate against the bacteria Bordetella
pertussis more commonly known as the “whooping cough.” This vaccine is routinely
given every 10 years to decrease the incidence of pertussis (CDC, 2013; CDC, 2016c).
But, for the maternal population, it is recommended by various leading health care
agencies such as ACOG, CDC, and ACIP that every pregnant woman receive the vaccine
with each pregnancy regardless of the date of her last Tdap vaccination; the most feasible
time for vaccine administration is between 27 and 36 weeks gestation when antibodies
can be created by the fetus, though postpartum before discharge is also acceptable (ACIP,
2013; ACOG, 2017; CDC, 2016a)
At the local birthing facility that served as the project site, I observed that many
postpartum mothers were refusing the administration of the Tdap vaccine. The mothers
either were unaware of the Tdap vaccine or stated that they planned on receiving the
vaccine during follow-up visits. In my review of the literature, I found few studies
available that were psychosocial in nature and that involved an assessment of decisions
for vaccination administration on the basis of increased knowledge levels; most studies
were based on epidemiologic data. Thus, the purpose of the doctoral project was to
provide a Tdap education toolkit for the nursing staff of the birthing center to support the
suggested theory and practice-focused question: Will an educational program and a
toolkit implemented for nursing staff members on the postpartum nursing unit ultimately
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result in improved Tdap vaccination rates among new postpartum mothers? In this
section, I will provide the results of data analysis and consider the implications of
findings. I will also offer recommendations for the project site and consider the strengths
and limitations of the project.
Findings and Implications
Data collection began after the successful submission of an IRB application and
permission for site use. A verbal invitation was extended to the clinical nursing staff and
a consent for them to participate was secured prior to the beginning of the project. I
collected data via pre- and post-Tdap knowledge testing of nursing staff and vaccine
attitude surveys. A total of 24 registered nurses between 22-64 years of age began project
participation; however, two participants did not complete as a result of retirement and
medical leave resulting in a final sample of 22 nurses participating. The birthing center
staff in the project consisted of 83.3% full-time and 16.7% part-time employees. The
participants’ education level included a college diploma in nursing (12.6%), associate’s
degree (8.3%), bachelor’s degree (70.8%), or master’s degree (8.3%).
I precluded parametric testing because pretest and posttest data were not normally
distributed. I used a Wilcoxon signed-rank test to ascertain whether the participating
RNs’ knowledge about the Tdap vaccine would be statistically increased posttest. There
was a statistically significant positive increase between the tests with the nurses scoring
higher on the posttests (z = -.366, p = .001). The average pretest score was 48.18 (the
minimum was 10% and the maximum, 80%) while the average posttest score was 65 with
a minimum of 30% and a maximum score of 90%.
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I also assessed the participating nurses’ attitudes about the Tdap vaccine using an
attitude survey (Appendix B) containing anchor words descriptive of negative, neutral, or
positive feelings about certain aspects of the Tdap vaccine. In using another Wilcoxon
signed-rank test, I found that there was a slight increase of positive feelings after the
education, but not enough to be considered statistically significant. This increase was
possibly more related to chance due to the small sample size and the close proximity of
mean scores rather than to the educational process. Of the 22 staff members who
participated in the project, the average score on the attitude pretest was 75.81 (0 indicates
a very negative attitude, 100 indicates a very positive attitude). On the posttest, the
average score was 78.45 with a minimum of 53 and a maximum of 97. However, the
2.64-point difference was not statistically significant.
Prior to the nurses receiving the educational toolkit, the QI team at the site audited
3 months of postpartum charts (100) from July through September and provided
information to me in a deidentified Microsoft Excel file. The QI team reviewed
documentation such as evidence of: (a) prior Tdap administration administered between
27-36 weeks, (b) ineligibility to receive the Tdap due to previous administration, (c) Tdap
refusal postpartum, and (d) Tdap vaccine administration in the postpartum period before
discharge. There were 96 postpartum charts audited from October-December after the
nurses received the Tdap educational toolkit assessing the same five variables. Overall,
more postpartum mothers received the Tdap vaccination before discharge post toolkit use
(15) than previous to its use (10; see Table 1). Of the 42 postpartum mothers who were
eligible for the vaccine in the postpartum period before the nurse training, 10 received
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vaccine, 12 refused the vaccine, and 20 are unaccounted for (see Table 1). That is, there
is no documentation in the medical record that the QI team was able to find describing
Tdap status for mothers. In the 3 months following the education, there were 11
postpartum mothers who refused the Tdap vaccine post education which was one fewer
than found in the 3-month period before the nurses began using the toolkit, and there
were only eight without documentation.
However, a chi-square analysis showed no statistically significant differences,
likely due to the small sample size. To reiterate, there was no documentation that the
Tdap vaccination was refused or given at all to 20 eligible mothers before the in-service
and eight after the education. It might have been the case that the nurses were more
attentive to documentation after the in-service, but I do not have evidence supporting this
conclusion.
Table 1
Chart Audit Results
Category
Postpartum Mothers
Received Tdap
Eligible for Tdap vaccine
Refused Tdap vaccine
Unaccounted for: eligible but
no documentation of Tdap
vaccine or Tdap refusal

Pre education

Post education

96
10
42
12
20

93
15
34
11
8

Note. Antenatal pregnant women’s charts were omitted from the sample.

There were some unanticipated limitations noted that could have impacted the
findings in this project. First, varied sample sizes may have been disproportionate which
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could have misrepresented the actual number of postpartum mothers who accepted the
Tdap vaccination. Next, all of the nursing staff did not completely participate during the
entire project which made the sample size small for the knowledge and attitude survey.
Also, many mothers became ineligible to receive the Tdap vaccine since it was
previously administered during the antenatal period between 27-36 weeks. Though being
vaccinated is beneficial for the infant during the antenatal period and is considered best
practice by the ACIP (2013), ACOG (2017), and the CDC (2016a), vaccinating mothers
in the postpartum phase before discharge from the hospital would still have been
protective of the infant. Postpartum Tdap vaccination would still be considered best
practice since it would provide a cocooning type of immunity protection to safeguard the
infant from pertussis until they are vaccinated at 2 months of age (ACOG, 2017).
The implications as a result of the project indicate that there are opportunities for
improving vaccination rates among pregnant and women in the postpartum period before
discharge. Though the results of the chart audit were not as positive as they might have
been, it is apparent from the results that the staff members are more attentive to the Tdap
vaccination process as a result of the change in the number of charts with missing
information on refusal or on vaccination (a change from as many as 20 to as few as 8).
Accordingly, the site has agreed to repeat the educational process with staff members, to
address all who missed it the first time, and to serve as a reminder to those who forget to,
or are reluctant to discuss vaccination with postpartum mothers. In an effort to minimize
barriers to new mothers about the Tdap vaccine; continue to maintain positive vaccine
attitudes, and to change the persistent negative attitudes about the Tdap vaccine, a
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discussion group with the nurses on their own attitudes towards vaccines will be included
in the proposed education review for those nursing staff who missed the initial education.
As a result of the DNP project, healthcare professionals have gained additional
knowledge regarding the Tdap vaccination, and negatives attitudes about the Tdap
vaccine have started to change. Encouraging and empowering these staff members to
embrace and share more information with postpartum mothers about the positive benefits
that the Tdap vaccination can produce for their infant is a contribution to positive social
change. The reduction of vaccine hesitancy within the community will increase as more
and more scientific data is readily available and released so that nonmedically inclined
persons can make informed decisions.
Recommendations
Proposed recommendations for the birthing center at the conclusion of this project
include the following:
•

Set a monthly goal for Tdap vaccination rates in the postpartum period,
achieving 75% of eligible mothers to receive the vaccine with only 25%
refusal.

•

Change and update the current Tdap screening tool used during the admission
process to include more specific questions regarding the mother’s Tdap
vaccine administration history. Updated questions should include, “Had Tdap
vaccine.... Within 5 years? Within last 10 years, during pregnancy, in prenatal
care? or “Don’t know?”, “Pregnant or postpartum at time of screening,”
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“Gestational age when Tdap received (27-36 weeks),” and “Tdap refused....
Reason for Tdap refusal?”
•

Include the Tdap toolkit or comparable Tdap education (see Appendices A, B,
C, D, and E) as a part of the unit’s yearly formal training, maintaining the
updated information needed according to the CDC, ACOG, ACIP and other
certified obstetrical forums.

•

Work with the Information Technology (IT) department of the hospital to
incorporate a “vaccine assessment needed” screen pop-up box that would
appear if the vaccine screening has not been completed by the nursing staff.
Staff would not be able to discharge the mother from the system until the
screening information was completed.

All recommendations were made to the local nursing leadership, and they have agreed to
pursue all of them.
Contribution of the Doctoral Project Team
The process of working with the doctoral project team was an exercise in time
management and task orientation in that most of the responsibility for the project’s
progression consisted of the project team which included the DNP student as the project
leader, project site birthing center coordinator, unit educator and education department
staff, and the birthing center staff members. The DNP student leader made sure that the
guidelines for the project were followed per the governing policies of the IRB of both the
university as well as the participating site. The DNP student leader also prepared the
educational toolkit for the project participants, as well as conducting the secondary data

43
analysis with the pre and posttest knowledge and attitude surveys, and with the secondary
chart audit analyses. Other members of the team included the educational staff and nurse
manager at the project site. Their roles were pivotal in that they reviewed the educational
toolkit to give suggestions as to its completeness and validity of the subject matter.
Lastly, the nursing staff of the birthing center role was giving consent for participation,
attending an informal in-service, receiving the educational toolkit packets, taking a
pretest for knowledge and attitudes. They also incorporated the information from the
educational packets, then applied this new knowledge to their current postpartum
teaching methods prior to the mothers’ discharge, a positive social change. The DNP
student project leader then returned within a few months and met with the project
participants and administered a post knowledge test and attitude survey. Once the project
was completed, the team met again and the data results were reviewed. Birthing center
leadership has agreed to implement the recommendations made during the project and
can modify and utilize the Tdap toolkit to create a yearly mandatory educational module.
Strengths and Limitations of the Project
As with any project, there is the potential for strengths and limitations to occur.
This project’s strengths included leadership and staff buy-in, available statistical
information, and nursing staff familiarity of the subject. Leadership and staff buy-in was
an important factor because they already knew and understood the importance of Tdap
vaccine administration as it related to the project and the population that they served.
This was considered a strength for the project since the birthing center leadership and
staff already had guidelines in place that they were currently following to provide the
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Tdap vaccine during the postpartum period. The goal for the project was to have 26 of the
staff (100%) to participate. Out of 26 birthing center employees, 24 nurses total
participated with 1 nurse retiring and another absent on medical leave before project
completion. Available statistical information was considered a strength since data was
readily available at least daily to every three days as mothers delivered and then prepared
for discharge. This could also be seen as a limitation since the statistical data obtained
was dependent upon how many mothers actually delivered during the project’s timeline.
During the course of the project, the birthing center’s census had multiple declining
fluctuations that could have attributed to the staff’s inability to utilize information from
the toolkit, as well as how many postpartum mothers were available to obtain vaccine
administration. Nursing staff familiarity of the project subject was considered a strength
because it made maneuvering through the toolkit less intimidating. Most of the nursing
staff were familiar with the vaccine and already had a current established knowledge
base.
Limitations of the project would include the lack of postpartum mothers available
for the staff to share the toolkit information, the lack of staff participation, and the
inadequacy of the toolkit. According to Davis et al. (2017), toolkits are designed to
develop and organize tasks by specifically providing action-oriented recommendations
and tools such as surveys and guidelines. But because literature has shown that toolkits
have not been vigorously evaluated and show content variability, their use have not
always been able to show a positive impact on health and practice change outcomes
(Barac, Stein, Bruce & Barwick, 2014). Although I did show a statistically significant
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improvement in knowledge, the change in attitude was not realized. Thus, the resulting
impact on documentation and on the nursing staff’s ability to convince and persuade new
mothers about the importance of the vaccine may not have been as strong as it might
have.
The lack of participation of birthing center staff was also a limitation in that not
all staff came to the initial project in-service which led to the necessity of the project
leader having to follow-up with nursing staff during various alternative times. This
proved to be difficult since most of the participants worked varied shifts and some of the
nursing staff left their current position within the birthing center. Recommendations for
future project would be to attempt to include more participants by reaching out to other
local facilities with birthing centers who administer the Tdap vaccine in the postpartum
period before discharge. This would serve to increase the number of mothers who are
educated on the Tdap topic, and might change their attitudes towards the vaccine.
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Section 5: Dissemination Plan
To facilitate dissemination of project findings, I participated in the DNP project
setting hospital’s yearly skills day. The skills day is a forum featuring all hospital
departments and highlighting education that is instituted within those departments.
Educational information highlighted by each department is presented in various ways to
make sure that the other departments within the hospital are aware of the most current
best-practice information within their department. Skills day presented an opportunity for
me to disseminate findings from this project to other peers within the facility who may be
caring for patients who are currently pregnant or have newborns under 1 year of age, and
who are unaware of the proper administration information concerning the Tdap vaccine.
The knowledge gleaned from this project is significant since as stated in Section 2, there
are few studies that address the attitudes of nurses about the Tdap vaccine. I also am
considering presenting the findings of this project to a broader audience via a poster
presentation or podium presentation.
Analysis of Self
Self-analysis of my roles as practitioner, scholar, and project manager is
important because it allows for an opportunity to reflect on my growth before, during,
and after the completion of this project. Being able to assess my strengths and
weaknesses allows me to emphasize the importance of being actively engaged in lifelong
learning experiences that I anticipate will propel me forward towards my professional
goals. As a practitioner, I have the ability to effect positive change in the lives of others
by (a) presenting evidence-based information to a broader audience, (b) examining how I
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practice in the clinical setting as a clinician, and (c) considering how to be a resource in
changing the ways care is provided to the population of clients whom I serve. The aim of
critical thinking and discernment of knowledge for me as a doctoral student and scholar is
to be able to evaluate, analyze, and synthesize information that I can then use within my
profession to create an atmosphere of awareness and learner responsibility. The
experience of managing this project has made me more proficient with communication
techniques and evidence-based research analysis and bolstered my leadership skills. It has
also given me the opportunity to use technical skills, motivate others, and network and
foster relationships which I need as a DNP-prepared professional.
The completion of this project posed some challenges I had to overcome. These
included the experience of enduring long hours of evaluating information from various
sources, making sure that all information that was pertinent to the success and completion
of the project was included, and having to restart the project. Overcoming these
challenges proved to be a lesson of perseverance that was needed to complete my
scholarly journey.
Summary
Pertussis is a historically eradicated respiratory illness among infants but is now
on the rise (Masseria et al., 2017). In this context, it is important for healthcare
professionals to become change agents and not only educate themselves but use
educational programs similar to the one in this project to teach mothers the importance of
vaccinating themselves with the Tdap vaccine. For the postpartum mother population, the
best time to have the Tdap vaccine administered is with every pregnancy between the
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27th and 36th week of gestation, according to ACOG (2017), CDC (2016c), ACIP
(2013), and other organizations. But, if mothers are not able to do so, having the
administration of the Tdap vaccine during postpartum before discharge from the hospital
is the next viable option (Cheng et al., 2015).
The aim of this project was to increase participating nurses’ level of nursing
knowledge about the Tdap vaccine so that they could share this knowledge with their
postpartum mothers and inadvertently raise the project institution’s Tdap vaccination
rates. Completion of this project provided an opportunity to add to the research available
on this subject since there is a lack of viable information and evidenced-based
interventions not only for scholars but for actual and potential mothers (see MacDougall
& Halperin, 2016). The project also assisted with the improvement of nursing knowledge
by using supplemental education about the Tdap vaccine so that it may be used in
conjunction with other learning materials available to them at the birthing center to assist
postpartum mothers in making decisions related to Tdap vaccine acceptance.
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Appendix A: Pre- and Posttest Knowledge Questions
1. Newborns have an automatic immunity to pertussis because the mother does:
a. Always true
b. Never true
c. Sometimes true depending on when the mother had her primary immunization and
the date of the last booster
d. Sometimes true depending on the mother’s nationality
2. The “100-day cough” occurs during one of three clinical courses of the disease:
a. Always during the paroxysmal stage
b. Never during the paroxysmal stage
c. Sometimes during the paroxysmal stage with the creation of thin mucous
d. Occasionally during the paroxysmal stage without the production of mucus
3. The current ideal recommendation for mothers to receive the Tdap vaccination is
a. Always during the 27th and 36th week gestation with each pregnancy
b. Never during the 27th and 36th week gestation of every pregnancy
c. During the 27th and 36th week gestation of every pregnancy only if vaccinated
previously
d. During the 27 through the 36th week gestation of every pregnancy only if not
previously vaccinated
4. Maternal education when given by the clinical nursing staff should
a. Always include the Vaccine Insurance Statement or be in violation of the Vaccine
Inquiry Act
b. Sometimes include the Vaccine Insurance Statement, only if in violation of the
Vaccine Inquiry Act
c. Always include the Vaccine Information statement regardless or you likely have
violated the Vaccine Inquiry Act
d. Never include the Vaccine Information Statement, since violation of the Vaccine
Inquiry Act is unlikely
5. When nursing staff utilize the “S” within the “Share a recommendation” as a talking
point for providers with mothers, they really are
a. “Stating” reasons the Tdap vaccine is under-utilized for the mother’s health risk
factors
b. “Suggesting” reasons the Tdap vaccination is under-utilized for the mother’s health
risk factors
c. “Stating” reasons the Tdap vaccine is recommended for the mother’s health risk
factors
d. “Suggesting” reasons the Tdap vaccine is refused for the mother’s health risk
factors
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6. When administering Boostrix vaccines, the nurse is knowledgeable that the vaccine can
be given to
a. infants, children, and adults always intramuscularly
b. infants, children and adults always intravenous
c. children and adults almost always intramuscularly and rarely intravenous
d. children and adult always intramuscularly and never intravenous
7. While treating a mother with a diagnosis of pertussis, the clinical nursing staff should
expect the doctor to order
a. Clotrimazole or Azithromycin
b. Clarithromycin or Azithromycin
c. Trimethoprim-sulfonamide or Azithromycin
d. Toyocamycin or Azithromycin
8. The nurse demonstrates her knowledge regarding Tdap storage and handling with
accuracy when she
a. stores the vaccine and protects it from the light at all times
b. thaws the vaccine before use, then refrigerates the remaining vaccine
c. refrigerates the vaccine between 2 degrees celsius and 8 degrees celsius(35F-46F)
d. discards the vial after its been opened within an ½ hour
9. A discharged mother calls the postpartum unit and states, “I received a Tdap vaccination
before discharge yesterday and now my upper arm is painful and swollen what should I
do?” The nurse verbalizes competence when she replies
a. “This is called anaphylaxis and you should be seen immediately”
b. “This is an arthus reaction, no treatment is needed but you should not receive
tetanus toxoid more frequently than necessary.”
c. “This are early warning signs of a systemic reaction. You will need to notify your
doctor for treatment.”
d. “This reaction is common, but you will need antibiotics prophylactically.”
10. Nursing staff is including the “Case” method within their teaching strategy when they
discuss with the mothers
a. The experiences of other mothers who accepted the Tdap vaccine and benefited
from its use.
b. The positive aspects of the Tdap vaccine.
c. Signs and symptoms of Tdap vaccine reactions.
d. Results of the most current vaccine study relating to postpartum mothers.
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Appendix B: Pre- and Posttest Attitude Questions
On a scale of 1 to 10, rank your viewpoint to each question using the anchor
words. 0-4 equates negativity, 5 is equating a neutral attitude, and 6-10 equates to a more
positive viewpoint.

Bad
0
Disagree
0
Unimportant
0
False

0
Invalid
Statement
0
Negative
0
Questionable
0
Uncertain
0
Unreliable
0
Unsatisfactory
0

Attitude Questions
My attitude towards all vaccinations is…….
1
2
3
4
5
6
7
8
9
I think new mothers should always get immunizations no
matter what kind.
1
2
3
4
5
6
7
8
9
I feel that it is essential that mothers are knowledgeable
about vaccines and their importance.
1
2
3
4
5
6
7
8
9
I agree that the Centers for Disease Control and Prevention
is a valuable resource for mothers regarding Tdap vaccine
information.
1
2
3
4
5
6
7
8
9
Postpartum mothers have the impression that clinical
nursing staff do not have knowledge nor time to provide
them vaccine education even if requested.
1
2
3
4
5
6
7
8
9
As a member of the clinical staff, I have enough education
to teach postpartum mothers about the Tdap vaccine.
1
2
3
4
5
6
7
8
9
Clinical nursing staff do a commendable job in providing
vaccine education to postpartum mothers.
1
2
3
4
5
6
7
8
9
The administration of the Tdap vaccine to postpartum
mothers decreases incidences of pertussis in their infants.
1
2
3
4
5
6
7
8
9
My current knowledge about the Tdap vaccine if provided
to postpartum mothers is dependable.
1
2
3
4
5
6
7
8
9
The current Tdap vaccine guidelines and standing orders
for staff are adequate.
1
2
3
4
5
6
7
8
9

Good
10
Agree
10
Important
10
True

10
Valid
Statement
10
Positive
10
Definitive
10
Certain
10
Reliable
10
Satisfactory
10
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Appendix C: Toolkit for Postpartum Nurses
The CDC’s (2016c) Vaccine Information Statement for the Tdap vaccine follows.
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Appendix D: Tips Sheet
Adapted from the Centers for Disease Control and Prevention Website (2017). Pertussis
(Whooping Cough). Retrieved from https//www.cdc.gov/pertussis/index.html

Tdap Vaccine: Information You Need but
Afraid to Ask
What is a vaccine?
•

A vaccine (vax-een) is a medication given to fight bad germs that try to take over your
body to make you and your baby sick. -This medicine is used to fight the bad germ whose
name is Pertussis (Per-tus-sis).
• This germ will cause you or your baby to cough really hard for a long time, and
you might not be able to breath. When you cough, the germs float through the air and
your baby breathes it in and gets an infection. This is called “whooping cough.”
• Moms can get better faster than their babies. If your baby can not breath well, and
coughs for a long time, they will be put in the hospital. If the baby gets sicker, he or she
could later die from this germ if not treated with antibiotics.

What is the name of the vaccine?

• There are two vaccines for moms called...1) Boostrix (Boo-strix) or 2) Adacel (Adaseal)
• They are medicine that is given with a with a needle in your arm. Yes...it is a shot.

How many times do I have to take this shot?
•

You only need to get this shot once every 10 years if it was
given to you as a child.

•

If you did not get the medicine (vaccine), you can get it when you are 27-36 weeks
pregnant or after you have your baby before you go home from the hospital. Your choice.
BUT....because you did not get the medicine when you were a child, you would need 2
more shots to be done for 10 years.

What will it do to me? Will it make me sick?
•

It will keep you and your baby from getting sick from the bad germ!

•

No, it will not make you sick, and it will not “give” you pertussis the bad germ. What the
medicine (vaccine) will do is cause your body to make super ninja fighting cells to find,
fight, and kill the bad pertussis germs.

•

Like with any medicine, it might make you feel bad before you feel better. People
sometimes feel this way because of the ingredients in the medicine. The feeling will go
away.
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•

You might have a sore arm, swelling or a rash from the shot. Some
people get a headache, sore throat, low fever, diarrhea, have a tummy
ache, or throw-up. If you feel worse.... call the doctor.

I’m sorry, I’m scared and I don’t believe you......
•

That’s ok, we are here to help you. On your computer, iPad or your cell phone google
a. For medication information sheets type:
www.vis/current-vis.html or www.cdc.gov/vaccines/hcpvis/currentvis.html
b. For a list of side effects from the medicine type:
www.cdc.gov/vaccines/vac-gen/side-effects.htm
c. For a video of what a baby looks like coughing with that bad germ
pertussis type: https://youtu.be/S3oZrMGDMMw
d. For a video of an adult with whooping cough type:
https://youtu.be/31tnXPlhA7w
e. Cleveland Clinic doctor explaining whooping cough type:
https://youtu.be/84JvqZbnwiQ

If you have questions, please ask your doctors and nurses.... we are
here to help you.
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Appendix E: Educational Program for Postpartum Staff Nurses
Educational Curriculum Plan Example (for in-services etc. to obtain CEUs)
Student: Birthing center staff nurses
Title of Project: Targeted Education for the Prevention of Vaccine Refusal
Problem: The lack of resources for nursing staff that can be used to bring insight to new
mothers about the importance of the Tdap vaccine.
Purpose: The purpose of this study is to development an educational process for the
postpartum nursing staff and provide them with a toolkit supporting the administration of
the Tdap vaccine during the postpartum inpatient stay for eligible mothers.
Practice Focused Question: Will an educational program and a toolkit implemented for
nursing staff members on the postpartum nursing unit ultimately result in improved
TDAP vaccination rates among new postpartum mothers?

Objectives
Content
At the
Outline
conclusion of
this
educational
experience
the learner
will be able
to 1. Define the 1.Introduction
significance
a. Problem
and the
purpose of
the
educational
curriculum
plan for the
Tdap
educational
toolkit.

Evidence

Method of
presenting
(See
Appendix E)

1A. Centers for
1. Oral
Disease Control
and Prevention
(CDC, 2016). Who
should get
diphtheria, tetanus
and whooping
cough vaccines:
Babies and
children, pregnant
women and adults.
Retrieved from
cdc.gov/vaccines/v
pd/dtaptdap/public/index.ht

Method of
Evaluation
P/P Item

Pre &
Posttest on
knowledge
and attitude
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ml
1A. Centers for
Disease Control
and Prevention
(CDC, 2016).
Pregnant women
and tdap
vaccination,
internet panel
surveys, United
States April 2013
and April 2014.
Retrieved from
https://www.cdc.go
v/vaccines/imz2. Define
Pertussis

2. A. What is
pertussis
B. Causes &
Transmission
C.
Treatmen
t -Slide
3

2 A, B, C. Center
for Disease Control
(2017). Pertussis.
Retrieved from
https://www.cdc.go
v/pertussis/clinical/
diseasespecifics.html

Oral
PowerPoint
Handout

Pre-&
Posttest on
knowledge
and attitude

3. Discuss
Tdap
background,
clinical
disease
course &
current
vaccination
trends

3.Stage 1
Catarrhal

3. Center for
Disease Control
(2017). Clinical
features. Retrieved
from
https://www.cdc.go
v/pertussis/clinical/
features.html

Oral
discussion

Pre-&
Posttest on
knowledge
and attitude

Stage 2
Paroxysmal
Stage 3
Convalescent
-Slide 4

4. Fast facts

4. A.
Recommended
dosage for
pregnant/postp
ar-tum women
B. Pertussis
cases in the
United States

PowerPoint
4. Center for
Disease Control
(2017) Fast facts.
Retrieved from
https://www.cdc.go
v/pertussis/fastfacts.html
Center for Disease

Oral
discussion

Pre-&
Posttest on
knowledge
and attitude
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C. Where the
name come
from
D. When not to
administer the
vaccine
Slide 5

5.
Vaccination
trends
-Slide 6

6. Learning
theories
related to
Tdap vaccine

6. A. Social
learning theory
B. Theory of
planned
behavior
C. Health
belief model

Control (2018).
Vaccine handling
and storage toolkit.
Retrieved from
https://www.cdc.go
v/vaccines/hcp/adm
in/storage/toolkit/in
dex.html

PowerPoint

5. Center for
Oral
Disease Control
discussion
(2018).
Surveillance and
PowerPoint
reporting. Retrieved
from
https://www.cdc.go
v/pertussis/downloa
ds/pertuss-survreport.pdf

Pre-&
Posttest on
knowledge
and attitude

6. A. Rosenstock,
Oral
I., Stretcher, V. &
discussion
Becker, M. (1988).
Social learning
theory and the
health belief
model.
Health Education
Quarterly, 15(2),
175-183.
B. Myers, K.
(2016). Predictors
of maternal
vaccination in the
United States: An
integrative review
of the literature.
Vaccine, 34, pp.
3942-3949.
Retrieved from
http://dx.doi.ort110:
1016/j.vaccine.201
6.06.042
C. Jones and

Pre-&
Posttest on
knowledge
and attitude
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7. Best
A. Centers for
practice
Disease
recommendat Control
ions
B. Advisory
Committee on
Immunization
Practices
C. American
Colleges of
Obstetricians
and
Gynecology
-Slide 8

Bartlett (N.D.)
7. A. Center for
Oral
Disease Control
discussion &
(2017). Pregnancy
and whooping
cough. Retrieved
from
https://www.cdc.go
v/pertussis/pregnant
/mom/getvaccinated.html
B. Center for
Disease Control
(2013). Advisory
Committee on
Immunization
Practices (ACIP).
Retrieved from
ttps://www.cdc.gov
/mmwr/preview/m
mwrhtml/mm6207a
4.htm
C. American
Colleges of
Obstetricians and
Gynecologists
(2017). Update on
Immunization and
Pregnancy:
Tetanus, diphtheria,
and pertussis
vaccination.
Retrieved from
https://www.acog.o
rg/ClinicalGuidance-andPublications/Comm
ittee_Opinions/Co
mmittee_on_Obstet
ric_Practice/Update
_on_Immunization
_and_Pregnancy_T

PowerPoint

Pre-&
Posttest on
knowledge
and attitude
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etanus_Diphtheriaand-PertussisVaccination

8. Tdap
Vaccines

8. Medication
A. Adacel
B. Boostrix
-Slides 9, 10,
11, & 12

Handout
A. United States
National Library of Oral
Medicine (2017).
Discussion
Adacel tdap: Drug
label information.
PowerPoint
Retrieved from
https://dailymed.nl
m.nih.gov/dailymed
/drugInfo.cfm?setid
=a41b7601-34f24a88-a406f53011fb7de1#S16

Pre-&
Posttest on
knowledge
and attitude

B. United States
National library of
Medicine (2016).
Boostrix: Drug
label information.
Retrieved from
https://dailymed.nl
m.nih.gov/dailymed
/search.cfm?labelty
pe=all&query=Boo
strix
9. Provider
Talking
Points

A. Assess
vaccination
status

American College
Oral
of Nurse Midwives discussion
(2014). Talking
points for providers
B. Share a
about immunization
recommendatio in pregnancy and
n
postpartum.
Retrieved from
C. Personalized http://www.midwif
the discussion
e.org/ACNM/files/c
cLibraryFiles/Filen
D. Finish
ame/000000004397 PowerPoint
strong
/VaccinationTalkin

Pre-&
Posttest on
knowledge
and attitude
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10. Learning
resources

Slide 16

gPointsforProviders
-091514.pdf

A. Centers for
Disease
Control
Vaccine
Storage and
Handling
Toolkit
B.
Immunization
Action
Coalition
vaccine
information
statements
C. Talking
Points for
Providers
about
Immunization
in Pregnancy
and Postpartum
D.
Administering
Vaccines:
Dose, Route,
Site, and
Needle size
E. Vaccines
and
preventable
Diseases

A.
https://www.cdc.go
v/vaccines/hcp/adm
in/storage/toolkit/st
orage-handlingtoolkit.pdf

- Slide 17

B.
http://www.immuni
ze.org/vis/
C.
http://www.midwif
e.org/ACNM/files/c
cLibraryFiles/Filen
ame/000000004397
/VaccinationTalkin
gPointsforProviders
-091514.pdf
D.
http://www.immuni
ze.org/catg.d/p3085
.pdf

E.
https://www.cdc.go
v/vaccines/vpd/dtap
-tdaptd/hcp/administerin
g-vaccine.html

Oral
discussion
Handout

Pre-&
Posttest on
knowledge
and attitude

